The clinical use of class IC antiarrhythmic drugs.

Article Details

Citation
Copy to clipboard

Abi Samra F

The clinical use of class IC antiarrhythmic drugs.

J La State Med Soc. 1989 May;141(5):27-31.

PubMed ID
2499646 [ View in PubMed
]
Abstract

Flecainide, encainide, and propafenone belong to class IC antiarrhythmic drugs. They are new and potent drugs which markedly depress Phase 0 of the action potential without affecting repolarization. Class IC drugs are very potent suppressors of premature ventricular complexes but their efficacy in the treatment of ventricular tachycardia is only comparable to that of class IA agents. Although noncardiac side effects are minimal, myocardial depression and serious proarrhythmic effects are not infrequently noted. A thorough understanding of the pharmacodynamics and toxicity potential of these drugs is therefore essential for their safe usage.

DrugBank Data that Cites this Article

Drugs